About Us

- Andreas Clemmensen, CEO

“We founded IQopta at Copenhagen’s Cluster for Molecular Imaging (CMI) and Rigshospitalet to remove a recurring bottleneck across the full lifecycle from drug development to clinical routine: image analysis was throttling the science. We didn’t want to build yet another piece of software for specialists to learn — we wanted to put an AI layer underneath the workflows clinicians and researchers already trust.”


Our Team

We are already collaborating with leading academic groups and industry partners across nuclear medicine and radiopharmaceutical drug development, making IQopta the next step toward faster, smarter medical image analysis.